Research News

COVID-19 Vaccine less efficient in Immunocompromised patients

This review, led by Dr Raghav Sundar and Dr Soon Yu Yang, show that covid-19 vaccines provide significantly lower protection in immunocompromised patients. It highlights the importance of a second dose of covid-19 vaccine and recommends administration of a third covid-19 vaccines dose to confer improved protection for immunocompromised patients.

 

Read more: https://doi.org/10.1136/bmj-2021-068632

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Spatially Resolved, Tumour Ecosystems in Gastric Cancer Progression

Gastric cancer (GC) has significant global mortality with high heterogeneity. A study of 226 GC samples from 121 patients integrated …

Read More →
Research News

Harnessing TME: Breaking Down EMT Barriers in Cancer Treatment

The tumour microenvironment (TME) plays a pivotal role in cancer progression, metastasis, and therapeutic resistance. Comprised of diverse cells, extracellular …

Read More →
Research News

Unveiling p53’s Role in DNA Protection: New Cancer Insights

Research led by N2CR member Dr. Cheok Chit Fang found that the tumour suppressor protein p53 protects DNA during replication …

Read More →